Institutional members access full text with Ovid®

Impact of azathioprine on the prevention of postoperative Crohn's disease recurrence: Results of a prospective, observational, longterm followup study

Domènech, Eugeni MD, PhD1,*; Mañosa, Míriam MD1; Bernal, Isabel MD1; Garcia‐Planella, Esther MD1; Cabré, Eduard MD, PhD1; Piñol, Marta MD2; Lorenzo‐Zúñiga, Vicente MD, PhD1; Boix, Jaume MD1; Gassull, Miquel A. MD, PhD1

doi: 10.1002/ibd.20359
Original Clinical Articles

Background:: Postoperative recurrence (PR) occurs early after intestinal resection in >75% of Crohn's disease (CD) patients. No well‐established strategy for long‐term PR prevention is available. The aim was to prospectively evaluate the long‐term endoscopic and clinical outcomes of postoperative CD on maintenance treatment with azathioprine (AZA), especially in patients who developed endoscopic lesions confined to the ileocolic anastomosis.

Methods:: Long‐term AZA therapy (2–2.5 mg/kg/day) was initiated immediately after surgery in 56 consecutive patients who underwent a curative intestinal resection. Clinical and biological assessments every 3 months, as well as yearly endoscopic evaluation, were performed until the end of the study or clinical PR (CPR).

Results:: Thirty‐seven patients (70%) showed mucosal lesions at endoscopy after a median of 12 months (range 12–60); however, in 15 of these patients lesions were confined to the anastomosis and only 6 showed endoscopic progression, but none of them developed CPR. Among the remaining 22 patients with endoscopic PR (EPR), 23% suffered a CPR during follow‐up. Thirty percent of patients remained free of EPR after a median follow‐up of 33 months (range 12–84). The cumulative probability of EPR was 44%, 53%, 69%, and 82%, at 1, 2, 3, and 5 years, respectively. No predictive factors of EPR were found.

Conclusions:: Early postoperative use of AZA seems to delay EPR development in comparison to historical series or placebo groups in randomized controlled trials. Although usually considered as endoscopic recurrence, those lesions confined to the ileocolonic anastomosis are not likely to progress or to become symptomatic in the short term.

1Department of Gastroenterology, Hospital Universitari Germans Trias i Pujol, Badalona, Catalonia, Spain

2Department of Surgery, Hospital Universitari Germans Trias i Pujol, Badalona, Catalonia, Spain

* Gastroenterology Department, Hospital Universitari Germans Trias i Pujol, 5a planta edifici general, Ctra. del Canyet, s/n, 08916 Badalona, Spain (e‐mail: edomenech.germanstrias@gencat.net)

Received 13 July 2007; Accepted 5 November 2007

Published online 8 January 2008 in Wiley InterScience (www.interscience.wiley.com).

Grant sponsor: CIBERehd of Fondo de Investigación Sanitaria of the Instituto de Salud Carlos III, from the Spanish Ministry of Health.

E. D., M. M., E. G.‐P., E. C., and M. G. are part of CIBERehd.

© Crohn's & Colitis Foundation of America, Inc.
You currently do not have access to this article

To access this article:

Note: If your society membership provides full-access, you may need to login on your society website